V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006158 | 10003967 | 1.65 | 50.9 | Disease modification (D) | 2017-05-18 | 2017-07-27 | Capecitabine + Oxaliplatin 21day | N | null | 10361811 | CAPECITABINE + OXALIPLATIN |
| 10006159 | 10003969 | 1.71 | 74.799 | Curative (C) | 2019-04-03 | 2019-04-22 | Irinotecan + Modified De Gramont | N | N | 10361864 | IRINOTECAN + MDG |
| 10006160 | 10003970 | 1.67 | 67.1 | Curative (C) | 2018-03-30 | 2018-04-01 | Paclitaxel 7 day | 2 | N | 10361864 | PACLITAXEL |
| 10006161 | 10003970 | 1.78 | 94.2 | Curative (C) | 2019-01-27 | 2019-01-27 | PEMBROLIZUMAB | 99 | N | 10361864 | PEMBROLIZUMAB |
| 10006162 | 10003971 | 1.68 | 91.3 | null | 2017-05-06 | 2017-05-14 | Rituximab | N | N | 10362264 | RITUXIMAB |
| 10006163 | 10003971 | 1.9 | 80 | Palliative (P) | 2018-07-30 | 2018-09-06 | Rituximab (Maintenance) | N | N | 10362264 | RITUXIMAB |
| 10006164 | 10003973 | 1.88 | 104 | Curative (C) | 2016-07-20 | 2016-09-27 | Irinotecan + Modified De Gramont | N | N | 10362905 | IRINOTECAN + MDG |
| 10006165 | 10003973 | 1.83 | 0 | Palliative (P) | 2017-05-14 | 2017-05-23 | Docetaxel | 2 | N | 10362905 | DOCETAXEL |
| 10006166 | 10003974 | 1.69 | 70.6 | Palliative (P) | null | 2016-02-17 | Oxaliplatin + Modified de Gramont | 02 | N | 10362986 | OXALIPLATIN + MDG |
| 10006167 | 10003975 | 1.85 | null | Curative (C) | 2019-02-27 | 2019-03-03 | CHOP R - 21 days | 99 | null | 10362995 | CHOP R |
| 10006168 | 10003976 | 1.72 | 50.9 | Palliative (P) | 2019-05-17 | 2019-05-18 | Irinotecan + Modified De Gramont | 2 | N | 10363023 | IRINOTECAN + MDG |
| 10006169 | 10003978 | 1.7 | 42.3 | Palliative (P) | 2016-07-06 | 2016-07-14 | Irinotecan + Modified De Gramont | N | null | 10363044 | IRINOTECAN + MDG |
| 10006170 | 10003979 | 1.56 | null | Palliative (P) | 2013-06-26 | 2013-09-20 | Docetaxel 100mg/m2 (21 day) | null | Y | 10363343 | DOCETAXEL |
| 10006171 | 10003979 | 1.77 | 65.6 | Disease modification (D) | 2018-07-13 | 2018-08-10 | FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 10363343 | OXALIPLATIN + MDG |
| 10006172 | 10003980 | 1.69 | 116 | Palliative (P) | 2017-03-17 | 2017-07-31 | PEMBROLIZUMAB | 02 | N | 10363636 | PEMBROLIZUMAB |
| 10006173 | 10003981 | 1.6 | 52.7 | Curative (C) | null | 2019-03-12 | Trastuzumab Subcutaneous | 2 | null | 10363722 | TRASTUZUMAB |
| 10006174 | 10003983 | 1.66 | null | Palliative (P) | 2017-08-05 | 2017-09-14 | Docetaxel | N | N | 10363886 | DOCETAXEL |
| 10006175 | 10003987 | 1.73 | 100 | Disease modification (D) | 2018-04-26 | 2018-06-07 | CHOP R | 02 | N | 10364258 | CHOP R |
| 10006176 | 10003987 | 1.71 | null | Palliative (P) | 2019-05-04 | 2019-05-18 | CHOP R - 21 days | 02 | Y | 10364258 | CHOP R |
| 10006177 | 10003989 | 1.61 | 83.4 | Palliative (P) | 2018-05-23 | 2018-05-25 | CHOP R - 21 days | N | N | 10364563 | CHOP R |
| 10006178 | 10003990 | 1.63 | null | Curative (C) | 2016-07-27 | 2017-04-07 | Irinotecan + Modified De Gramont | N | N | 10364593 | IRINOTECAN + MDG |
| 10006179 | 10007115 | 1.75 | 83.4 | Palliative (P) | null | 2016-12-05 | Capecitabine + Oxaliplatin 21day | N | null | 10365019 | CAPECITABINE + OXALIPLATIN |
| 10006180 | 10003992 | 1.84 | 80 | Palliative (P) | 2018-03-31 | 2018-03-31 | Rituximab | N | N | 10365102 | RITUXIMAB |
| 10006181 | 10003992 | 1.78 | null | Curative (C) | 2016-11-07 | 2016-12-31 | Paclitaxel 7 day | N | N | 10365102 | PACLITAXEL |
| 10006182 | 10003994 | 1.7 | 73.7 | Disease modification (D) | 2017-06-06 | 2017-07-01 | Rituximab (Maintenance) | N | N | 10365796 | RITUXIMAB |
| 10006183 | 10003995 | 1.69 | 69.2 | Palliative (P) | 2018-05-19 | 2018-05-19 | FLUOROURACIL + IRINOTECAN | 02 | N | 10365831 | IRINOTECAN + MDG |
| 10006184 | 10007117 | 1.6 | 72.2 | Curative (C) | 2017-11-22 | 2017-12-07 | Oxaliplatin + Modified de Gramont | 2 | N | 10366122 | OXALIPLATIN + MDG |
| 10006185 | 10007117 | 1.85 | 63.6 | Curative (C) | 2016-01-04 | 2016-02-07 | PEMBROLIZUMAB | N | N | 10366122 | PEMBROLIZUMAB |
| 10006186 | 10003996 | 1.84 | 69.6 | Not known (9) | 2017-07-19 | 2017-07-19 | Rituximab | N | N | 10366173 | RITUXIMAB |
| 10006187 | 10003996 | 1.79 | 92.6 | Curative (C) | 2018-09-06 | 2019-01-20 | Docetaxel | N | N | 10366173 | DOCETAXEL |
| 10006188 | 10003997 | null | 70.8 | Disease modification (D) | 2015-07-02 | 2015-07-09 | Rituximab | N | N | 10366268 | RITUXIMAB |
| 10006189 | 10003998 | 1.66 | 86.5 | Disease modification (D) | 2017-08-01 | 2017-08-03 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | 2 | 10366482 | PACLITAXEL |
| 10006190 | 10003998 | null | 76.6 | Palliative (P) | 2015-09-19 | 2017-05-12 | CHOP R | 02 | N | 10366482 | CHOP R |
| 10006191 | 10008924 | 1.78 | 87.2 | Adjuvant (A) | 2017-05-25 | 2017-07-12 | Rituximab (Maintenance) | 99 | N | 10366608 | RITUXIMAB |
| 10006192 | 10003999 | 1.62 | 56.4 | Disease modification (D) | 2016-09-02 | 2016-09-02 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 10366662 | RITUXIMAB |
| 10006193 | 10004000 | 1.71 | 78.8 | Palliative (P) | 2017-07-07 | 2017-07-20 | Oxaliplatin + Modified de Gramont | 02 | N | 10366762 | OXALIPLATIN + MDG |
| 10006194 | 10004003 | 1.68 | 84 | Palliative (P) | 2015-12-21 | 2015-12-22 | CHOP R | 2 | N | 10366795 | CHOP R |
| 10006195 | 10004004 | 1.77 | null | Curative (C) | 2017-07-22 | 2017-07-23 | CAPECITABINE + OXALIPLATIN | N | N | 10366799 | CAPECITABINE + OXALIPLATIN |
| 10006196 | 10004005 | 1.7 | 84.999 | Palliative (P) | 2018-07-29 | 2018-07-31 | IRINOTECAN + MDG | null | null | 10367228 | IRINOTECAN + MDG |
| 10006197 | 10004007 | 1.53 | 66.6 | Palliative (P) | 2017-12-05 | 2017-12-13 | PEMBROLIZUMAB | 02 | N | 10367384 | PEMBROLIZUMAB |
| 10006198 | 10004009 | 1.66 | 97.5 | Curative (C) | 2016-07-01 | 2016-07-03 | Rituximab | N | N | 10367384 | RITUXIMAB |
| 10006199 | 10004009 | 1.7 | 76 | Disease modification (D) | 2017-05-28 | 2017-06-09 | TRASTUZUMAB | N | N | 10367384 | TRASTUZUMAB |
| 10006200 | 10004011 | 1.76 | null | Palliative (P) | 2015-03-19 | 2015-06-12 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 10367523 | RITUXIMAB |
| 10006201 | 10004012 | 1.78 | 83.75 | Palliative (P) | 2014-10-18 | 2014-11-07 | Rituximab | N | N | 10367539 | RITUXIMAB |
| 10006202 | 10004012 | 1.8 | 94.15 | Neo-adjuvant (N) | 2017-09-05 | 2017-09-14 | CHOP R - 21 days | 2 | N | 10367539 | CHOP R |
| 10006203 | 10004013 | 1.71 | 137 | null | 2017-03-09 | 2017-03-21 | Capecitabine + Oxaliplatin 14day | N | N | 10367650 | CAPECITABINE + OXALIPLATIN |
| 10006204 | 10004013 | null | null | Palliative (P) | 2014-05-07 | 2016-02-24 | Capecitabine + Oxaliplatin 21day | N | N | 10367650 | CAPECITABINE + OXALIPLATIN |
| 10006205 | 10004015 | 1.62 | 65 | Palliative (P) | 2017-05-21 | 2017-05-21 | CHOP R - 21 days | N | N | 10367936 | CHOP R |
| 10006206 | 10004016 | 1.71 | null | Palliative (P) | null | 2018-09-27 | Irinotecan + Modified De Gramont | 2 | null | 10368106 | IRINOTECAN + MDG |
| 10006207 | 10007125 | 1.6 | 53.1 | Palliative (P) | 2016-12-27 | 2016-12-27 | TRASTUZUMAB | 2 | N | 10368445 | TRASTUZUMAB |